Sarcopenia

Jun 01, 2020

Longeveron Announces Japanese Approval of Clinical Trial for Treatment of Aging Frailty With Longeveron's Stem Cells

May 04, 2020

The Pandemics within the Pandemic

Jan 09, 2020

MYOS CEO Joseph Mannello Issues Letter to Shareholders

Nov 20, 2019

MYOS RENS' Fortetropin® Clinical Trial Results to be Presented by William J. Evans, Ph.D., at the International Conference on Frailty and Sarcopenia Research

Nov 13, 2019

AMRA Medical Abstract Selected for AASLD's "Best of The Liver Meeting" Showcase

Oct 23, 2019

New Study Reveals Method Linking AMRA Medical's Muscle Biomarkers and Function

Jul 22, 2019

Astaxanthin Leader AstaMed(TM), fuels The Run(TM) and American Running League(TM), supporting Naturopathic Doctors and Aspirational Aging for Patients ages 35-105 in all 50 States

Feb 19, 2019

Longeveron Discusses Latest Stem Cell Findings for Aging Frailty at the International Conference on Frailty & Sarcopenia Research

Feb 01, 2019

FitTrace Integrates DXA Body Composition Measurements with Fitbit

Nov 05, 2018

Pharmacy Sarcopenia Treatment Market to Showcase Healthy Expansion at 4.2% CAGR During 2018 - 2026 Persistence Market Research

Oct 16, 2018

Study finds seniors with sarcopenia-derived muscle loss improve with new proprietary natural astaxanthin formulation